SCHEMBL6505370

SCHEMBL6505370

C[CH]NCC(=O)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.61
MEN1 O00255 4/20 0.61
KMT2A Q03164 4/20 0.61
CYP3A4 P08684 4/20 0.61
HPGD P15428 4/20 0.61
CYP1A2 P05177 3/20 0.61
CYP2C9 P11712 3/20 0.61
CYP2C19 P33261 3/20 0.61
MAPT P10636 5/20 0.56
KDM4E B2RXH2 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
MAPK1 P28482 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
ALOX15 P16050 1/20 0.56
CES1 P23141 1/20 0.56
CYP2D6 P10635 2/20 0.51
GAA P10253 1/20 0.51
RAB9A P51151 3/20 0.50
NPC1 O15118 2/20 0.50
LMNA P02545 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL350086 0.82 ALDH1A1 (0.62) ALDH1A1MEN1KMT2ACYP3A4HPGD
SCHEMBL12125121 0.80 ALDH1A1 (0.61) ALDH1A1MEN1KMT2ACYP3A4HPGD
SCHEMBL28102384 0.77 MEN1 (0.52) ALDH1A1MEN1KMT2ACYP3A4HPGD
SCHEMBL260807 0.77 KMT2A (0.62) ALDH1A1MEN1KMT2ACYP3A4HPGD
SCHEMBL5932634 0.76 HPGD (0.68) ALDH1A1MEN1KMT2ACYP3A4HPGD
Hydrochloric Acid SCHEMBL259354 0.75 KMT2A (0.60) ALDH1A1MEN1KMT2ACYP3A4HPGD
SCHEMBL23023262 0.74 ALDH1A1 (0.50) ALDH1A1MEN1KMT2ACYP3A4HPGD
SCHEMBL6931635 0.74 ALDH1A1 (0.49) ALDH1A1MEN1KMT2ACYP3A4HPGD
Bromide SCHEMBL10777716 0.74 HPGD (0.65) ALDH1A1MEN1KMT2ACYP3A4HPGD
Hydrochloric Acid SCHEMBL9432569 0.74 HPGD (0.65) ALDH1A1MEN1KMT2ACYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed